Notices. Notice and extension of comment period
274 words·~1 min read·
/register/2017/06/01/2017-11292·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 6560-58-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [CDC-2016-0090; Docket Number NIOSH 288-A] A Performance Test Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs; Extension of Comment Period AGENCY: National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).
ACTION: Notice and extension of comment period. SUMMARY: On September 15, 2016 the National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), published a notice in the **Federal Register** announcing a public meeting and request for public comment on a draft testing protocol. Written comments were to be received by December 7, 2016. NIOSH initially extended the public comment period to June 7, 2017 [81 FR 88687]. NIOSH is extending the public comment period for a second time to August 30, 2017.
The longer timeframe will allow companies to test the protocol with the proposed challenge agents. FOR FURTHER INFORMATION CONTACT: Deborah V. Hirst, NIOSH, Alice Hamilton Laboratories, 1090 Tusculum Avenue, MS-R-5, Cincinnati, Ohio 45226, telephone
(513)841-4141 (not a toll free number), Email: *DHirst@cdc.gov.* ADDRESSES: You may submit comments, identified by CDC-2016-0090 and Docket Number NIOSH 288-A, by either of the following two methods: • *Federal eRulemaking Portal: http://www.regulations.gov.* Follow the instructions for submitting comments. • *Mail:* National Institute for Occupational Safety and Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C-34, Cincinnati, Ohio 45226-1998. John Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. [FR Doc. 2017-11292 Filed 5-31-17; 8:45 am]